1 / 6

Reports and Intelligence: Global Ankylosing Spondylitis Mark

Global Ankylosing Spondylitis Market 2015-2019: Has been prepared based on an in-depth market analysis, trends forecast with inputs from industry experts. The report covers the Americas, the APAC region and the EMEA; it also covers the Global Ankylosing Spondylitis market landscape and its growth prospects in the coming years. Detailed report at: http://www.reportsandintelligence.com/global-ankylosing-spondylitis-2015-2019-market

mackgina111
Download Presentation

Reports and Intelligence: Global Ankylosing Spondylitis Mark

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Ankylosing Spondylitis Market Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Growth, Forecast 2015-2019 Published By : Technavio Published On : January, 2015

  2. Description About Ankylosing Spondylitis Ankylosing spondylitis is a subtype of spondylarthropathy. The primary symptoms of the disease are inflammatory spinal pain with subsequent limitation of spine mobility and chest expansion. Ankylosing spondylitis can be diagnosed using clinical signs, radiological signs (sacroiliitis) and the presence of HLA-B27 antigen. According to the NIH and NIAMS, ankylosing spondylitis is a type of arthritis, which affects the joints in the vertebral column severely. It is a progressive inflammatory disease that typically becomes evident during early to mid-adulthood, as per NORD. It can also lead to the loss of spinal mobility for the affected individuals. The cause of the disease is not known, however, the HLA-B27 gene plays a major role. Ankylosing spondylitis is hereditary in nature.

  3. Description Covered in this Report This report covers the present scenario and the growth prospects of the Global Ankylosing Spondylitis market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various drugs used in the treatment of ankylosing spondylitis. The market is segmented based on the mechanism of action of the drugs used to treat ankylosing spondylitis as illustrated below: • TNF Inhibitors • COX Inhibitors • Others For more inquiry, visit at: http://www.reportsandintelligence.com/enquire-about-report/170002

  4. KeyVendors Merck & Co. Pfizer Amgen Abbvie Janssen Pharmaceuticals

  5. Table of Content • 01. Executive Summary • 02. List of Abbreviations • 03. Scope of the Report • 04. Market Research Methodology • 05. Introduction • 06. Disease Overview • 07. Market Landscape • 08. Market Segmentation by Mechanism of Action • 09. Market Segmentation by Type of Molecule • 10. Market Segmentation by Route of Administration • Get full TOC at: http://www.reportsandintelligence.com/global-ankylosing-spondylitis-2015-2019-market/table-of-contents

  6. FOR MORE DETAILS Visit us at : http://www.reportsandintelligence.com/global-ankylosing-spondylitis-2015-2019-market Stay With Us: • TELEPHONE: Direct: +1 (617) 674-4143 • Toll Free: +1 (855) 711-1555E-MAIL: sales@reportsandintelligence.com 5933 NE Win Sivers Drive,#205, Portland, OR 97220United States

More Related